Risk factors for disease progression in COVID-19 patients

被引:87
作者
Chang, Min Cheol [1 ]
Park, Yu-Kyung [2 ]
Kim, Bong-Ok [3 ]
Park, Donghwi [4 ]
机构
[1] Yeungnam Univ, Dept Rehabilitat Med, Coll Med, Daegu, South Korea
[2] Daegu Hosp, Korea Workers Compensat & Welf Serv, Dept Internal Med, Daegu, South Korea
[3] Daegu Hosp, Korea Workers Compensat & Welf Serv, Dept Rehabil Med, Daegu, South Korea
[4] Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Phys Med & Rehabil, 877 Bangeojin Sunhwando Ro, Ulsan 44033, South Korea
基金
新加坡国家研究基金会;
关键词
Coronavirus disease; Risk factor: symptom aggravation; Chilling; Fever; Diabetes; DIABETES-MELLITUS; INFLAMMATION; AGE;
D O I
10.1186/s12879-020-05144-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundCoronavirus disease (COVID-19) is rapidly spreading worldwide. Although 10-20% of patients with COVID-19 have severe symptoms, little is known about the risk factors related to the aggravation of COVID-19 symptoms from asymptomatic or mild to severe disease states.MethodsThis retrospective study included 211 patients who were asymptomatic or with mild presentations of COVID-19. We evaluated the differences in demographic and clinical data between the cured (discharged to home) and transferred (aggravated to severe-stage COVID-19) groups.ResultsA multivariate logistic analysis showed that body temperature, chills, initial chest X-ray findings, and the presence of diabetes were significantly associated with predicting the progression to severe stage of COVID-19 (p<0.05). The odds ratio of transfer in patients with COVID-19 increased by 12.7-fold for abnormal findings such as haziness or consolidation in initial chest X-ray, 6.32-fold for initial symptom of chills, and 64.1-fold for diabetes.ConclusionsEven if patients are asymptomatic or have mild symptoms, clinicians should closely observe patients with COVID-19 presenting with chills, body temperature>37.5 degrees C, findings of pneumonia in chest X-ray, or diabetes.
引用
收藏
页数:6
相关论文
共 20 条
[1]  
[Anonymous], 2020, N ENGL J MED
[2]  
[Anonymous], 2020, AM J PHYS MED REHABI
[3]  
[Anonymous], J MED VIROL
[4]   Immunological Impacts of Diabetes on the Susceptibility of Mycobacterium tuberculosis [J].
Ayelign, Birhanu ;
Negash, Markos ;
Genetu, Meaza ;
Wondmagegn, Tadelo ;
Shibabaw, Tewodros .
JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
[5]   Human T cell immunosenescence and inflammation in aging [J].
Bektas, Arsun ;
Schurman, Shepherd H. ;
Sen, Ranjan ;
Ferrucci, Luigi .
JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 102 (04) :977-988
[6]  
Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253
[7]  
Chang MC, 2020, HEALTHCARE BASEL, V8
[8]   Serum cytokines and clinical features in patients with fever and thrombocytopenia syndrome [J].
Chen, Huanzhu ;
Lin, Chun ;
Fan, Zhiqiang ;
Yu, Wenjun ;
Cao, Manxiong ;
Ke, Changwen ;
Jiao, Xiaoyang .
CLINICA CHIMICA ACTA, 2019, 494 :22-30
[9]   Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept [J].
Chung, Hae Young ;
Kim, Dae Hyun ;
Lee, Eun Kyeong ;
Chung, Ki Wung ;
Chung, Sangwoon ;
Lee, Bonggi ;
Seo, Arnold Y. ;
Chung, Jae Heun ;
Jung, Young Suk ;
Im, Eunok ;
Lee, Jaewon ;
Kim, Nam Deuk ;
Choi, Yeon Ja ;
Im, Dong Soon ;
Yu, Byung Pal .
AGING AND DISEASE, 2019, 10 (02) :367-382
[10]  
Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x